Table 2 Clinical features of the surveyed pancreatic cancer patients
Cancer patients (n = 55) | ||||
|---|---|---|---|---|
Clinical features | Findings | No | % | |
Features | Biopsy | Adenocarcinoma | 49 | 92.3 |
Surgery | 9 18 30 | 16.4 33.7 55.5 | ||
Endoscopy | ||||
Ca19-9 positive | ||||
Cancer seats CT TAP | Cephalic tumor Corporeal cancer Caudal tumor | 26 21 10 | 48 38 18 | |
Cancer staging | Metastatic stage Locally advanced Localized | 31 15 9 | 56.4 27.3 16.4 | |
Chemotherapy | Adjuvant Chemotherapy: | 6 | 10.9 | |
Gemcitabine Folfirinox | 5 1 | 83.3 16.7 | ||
Palliative Chemotherapy: | 42 | 76.4 | ||
Gemcitabine Folfirinox | 20 15 | 47.6 35.7 | ||